Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models

International Immunopharmacology

Volumn 11, Issue 6, 2011, Pages 683-692

  Yang, Weimin ^a   Qiang, Dongjin ^a   Zhang, Min ^a   Ma, Limei ^a   Zhang, Yonghui ^a   Qing, Chen ^a   Xu, Yunlong ^b   Zhen, Chunlan ^a   Liu, Jikai ^b   Chen, Yan Hua ^c  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Acute lung injury; Cytokine; Inflammation; Isoforskolin; Lipopolysaccharide

Indexed keywords

DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FORSKOLIN DERIVATIVE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; ISOFORSKOLIN; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; EUKARYOTIC CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG LAVAGE; LUNG PERFUSION; LUNG WEIGHT; MALE; MONONUCLEAR CELL; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SEPTIC SHOCK; SURVIVAL RATE;

ACUTE LUNG INJURY; ANIMALS; CELL ADHESION; CELLS, CULTURED; COLEUS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FORSKOLIN; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LUNG; MICE; NEUTROPHILS; PEROXIDASE; RATS;

EID: 79955846739     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.01.011     Document Type: Article

References (49)

1. Repine JE. Scientific perspectives on adult respiratory distress syndrome. Lancet 1992;339:466-9.
2. Windsor AC, Mullen PG, Fowler AA. Acute lung injury: what have we learned from animal models? Am J Med Sci 1993;306:111-6.
3. Sutcliffe AJ. The future of ARDS. Injury 1994;25:587-93. (Pubitemid 24373364)
4. Jin Q, Xie X, Mu Q. Study on the chemical constituents from Coleus forskohlii. Nat Prod Res Dev 1990:6-9.
5. Yang W, Li X, Chen Z, Nie L, Wang B, Shen Z. Adenylate cyclase stimulation and ocular hypertension inhibition by forskolin analogs. Chin Ophthalmic Res 2001;19:1-3.
6. Yang W, Jin Q, Liu J, Qing C, Liu Y, Chen Z. Effect of three forskolin analogs in isolated lung and trachea strips of guinea pig. Chin Tradit Herb Drugs 2003;34:191-3.
7. Pinto C, Papa D, Hubner M, Mou TC, Lushington GH, Seifert R. Activation and Inhibition of Adenylyl Cyclase Isoforms by Forskolin Analogs. J Pharmacol Exp Ther 2008;325:27-36. (Pubitemid 351439155)
8. Seibert AF, Thompson WJ, Taylor A, Wilborn WH, Barnard J, Haynes J. Reversal of increased microvascular permeability associated with ischemia-reperfusion:role of cAMP. J Appl Physiol 1992;72:389-95.
9. Adkins WK, Barnard JW, May S, Seibert AF, Haynes J, Taylor AE. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury. J Appl Physiol 1992;72:492-7.
10. Mclntyre RC, Sheridan B, Agrafojo J, Fullerton DA. Selective inhibition of receptor-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Shock 1997;7:36-41. (Pubitemid 127654245)
11. Seeger W, Hansen T, Rossig R, Schmehl T, Schutte H, Kramer HJ, et al. Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability-effect of adenylate cyclase stimulation and phosphodiesterase inhibition. Microvasc Res 1995;50:1-17.
12. Hoffmann H, Hatherill JR, Crowley J, Harada H, Yonemaru M, Zheng H, et al. Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs. Am Rev Respir Dis 1991;143:289-93.
13. Michetti C, Coimbra R, Hoyt DB, Loomis W, Junger W, Wolf P. Pentoxifylline reduces acute lung injury in chronic endotoxemia. J Surg Res 2003;115:92-9. (Pubitemid 37323953)
14. Golbasi I, Akbas H, Ozdem S, Ukan S, Ozdem SS, Kabukcu H, et al. The effect of pentoxifylline on haemolysis during cardiopulmonary bypass in open-heart surgery. Acta Cardiol 2006;61:7-11. (Pubitemid 43198496)
15. Ruef P, Poeschl JM, Simon C, Altfelder F, Craciun E, Linderkamp O. Effect of activators and the phosphodiesterase inhibitors pentoxifylline and enoximone on the deformability of neutrophils in neonates and adults. Acta Paediatr 2004;93:1288-93. (Pubitemid 39273898)
16. Takeoka M, Sakai A, Ueda G, Ge RL, Ishizaki T, Panos RJ, et al. Dibutyryl cAMP inhibits endotoxin-induced increases in pulmonary vascular resistance and fluid filtration coefficient in the perfused rat lung. Tohoku J Exp Med 1997;183:273-84. (Pubitemid 28136569)
17. Sciuto AM, Strickland PT, Kennedy TP, Guo YL, Gurtner GH. Intratracheal administration of DBcAMP attenuates edema formation in phosgene-induced acute lung injury. J Appl Physiol 1996;80:149-57. (Pubitemid 26034857)
18. Chang SW, Sakai A, Voelkel NF. Dibutyryl-cAMP blocks endotoxin-induced lung injury in rats. Am Rev Respir Dis 1989;140:1814-7. (Pubitemid 20041073)
19. Watkins CA, Rannels DE. Effect of diabetes on metabolism of 5-hydroxytryptamine by rat lungs perfused in situ. Am Rev Respir Dis 1982;126:175-7. (Pubitemid 12090880)
20. Fisher AB, Dodia C, Linask J. Perfusate composition and edema formation in isolated rat lungs. Exp Lung Res 1980;1:13-21. (Pubitemid 11198603)
21. Dallal MM, Chang SW. Evans blue dye in the assessment of permeability-surface are product in perfused rat lungs. J Appl Physiol 1994;77:1030-5. (Pubitemid 24258345)
22. Kern DF, Malik AB. Microvascular albumin permeability in isolated perfused lung: effects of EDTA. J Appl Physiol 1985;58:372-5. (Pubitemid 15057745)
23. Fletcher MA, McKenna TM, Owens EH, Nadkarni VM. Effects of in vivo pentoxifylline treatment on survival and ex vivo vascular contractility in a rat lipopolysaccharide shock model. Circ Shock 1992;36:74-80.
24. Boyum A. Separation of lymphocytes, lymphocyte subgroups and monocytes: a review. Lymphology 1977;10:71-6. (Pubitemid 8098548)
25. Boyum A. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 1976(Suppl 5):9-15.
26. Idzko M, Dichmann S, Ferrari D, Di Virgilio F, la Sala A, Girolomoni G, et al. Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 2002;100:925-32. (Pubitemid 34832619)
27. Mul FPJ, Zuurbier AEM, Janssen H, Calafat J, van Wetering S, Hiemstra PS, et al. Sequential migration of neutrophils across monolayers of endothelial and epithelial cells. J Leukoc Biol 2000;68:529-37.
28. Cepkova M, Matthay MA. Pharmacotherapy of Acute Lung Injury and the Acute Respiratory Distress Syndrome. J Intensive Care Med 2006;21:119-43.
29. Metz C, Sibbald WJ. Anti-inflammatory therapy for acute lung injury. A review of animal and clinical studies. Chest 1991;100:1110-9.
30. Dinarello CA. Proinflammatory and Anti-inflammatory Cytokines as Mediators in the Pathogenesis of Septic Shock. Chest 1997;112:321S-9S.
31. Frutos-Vivar F, Nin N, Esteban A. Epidemiology of acute lung injury and acute respiratory distress syndrome. Curr Opin Crit Care 2004;10:1-6. (Pubitemid 38183917)
32. Gao J, Zeng BX, Zhou LJ, Yuan SY. Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats. Br J Anaesth 2004;92:277-9. (Pubitemid 38159672)
33. Gust Rene, Kozlowski JK, Stephenson AH, Schuster DP. Role of Cyclooxygenase-2 in Oleic Acid-Induced Acute Lung Injury. Am J Respir Crit Care Med 1999;160:1165-70. (Pubitemid 29487455)
34. Meyer J, Theilmeier G, Van Aken H, Bone HG, Busse H, Waurick R, et al. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure. Anesth Analg 1998;86:753-8. (Pubitemid 28177727)
35. Yamanaka K, Saluja AK, Brown GE, Yamaguchi Y, Hofbauer B, Steer ML. Protective effects of prostaglandin E1 on acute lung injury of caerulein-induced acute pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 1997;272:G23-30.
36. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L379-99.
37. Lin Q, Wang GF, Tang XY, Zou SL. Effects of dexamethasone on acute lung injury in rats induced by lipopolysacharide. Beijing Da Xue Xue Bao 2006;38:393-6.
38. Wang XQ, Zhou X, Zhou Y, Rong L, Gao L, Xu W. Low-dose dexamethasone alleviates lipopolysaccharide-induced acute lung injury in rats and upregulates pulmonary glucocorticoid receptors. Respirology 2008;13:772-80.
39. Wan M, Ling YL, Gu ZY, Zhang JL, Huang SS. Effects of endogenous nitric oxide on pulmonary artery hypertension and lung injury induced by endotoxin. Sheng Li Xue Bao 1999;51:80-6.
40. Sakai A, Voelkel NF. Dibutyryl cyclic adenosine monophosphate inhibits pulmonary vasoconstriction. Lung 1988;166:221-31.
41. Manimtim WM, Hasday JD, Hester L, Fairchild KD, Lovchik JC, Viscardi RM. Ureaplasma urealyticum Modulates Endotoxin-Induced Cytokine Release by Human Monocytes Derived from Preterm and Term Newborns and Adults. Infect Immun 2001;69:3906-15. (Pubitemid 32493312)
42. Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C. Luteolin Inhibits an Endotoxin-Stimulated Phosphorylation Cascade and Pro-inflammatory Cytokine Production in Macrophages. J Pharmacol Exp Ther 2001;296:181-7. (Pubitemid 32015077)
43. Agelaki S, Tsatsanis C, Gravanis A, Margioris AN. Corticotropin-Releasing Hormone Augments Proinflammatory Cytokine Production from Macrophages In Vitro and in Lipopolysaccharide-Induced Endotoxin Shock in Mice. Infect Immun 2002;70:6068-74. (Pubitemid 35192696)
44. Okonogi K, Gettys TW, Uhing RJ, Tarry WC, Adams DO, Prpic V. Inhibition of prostaglandin E2-stimulated cAMP accumulation by lipopolysaccharide in murine peritoneal macrophages. J Biol Chem 1991;266:10305-12. (Pubitemid 21906804)
45. Tsien WH, Sampson M, Sheppard H. The elevation of mouse thymus cell cyclic adenosine monophosphate (cAMP) by lipopolysaccharide. Immunopharmacology 1981;3:253-8. (Pubitemid 12226534)
46. Sweet MJ, Hume DA. Endotoxin signal transduction in macrophages. J Leukoc Biol 1996;60:8-26. (Pubitemid 26248877)
47. Monick MM, Hunninghake GW. Activation of second messenger pathways in alveolar macrophages by endotoxin. Eur Respir J 2002;20:210-22. (Pubitemid 34822945)
48. Hanoune J, Defer N. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol 2001;41:145-74. (Pubitemid 32385886)
49. Risoe PK, Wang Y, Stuestol JF, Aasen AO, Wang JE, Dahle MK. Lipopolysaccharide attenuates mRNA levels of several adenylyl cyclase isoforms in vivo. Biochim Biophys Acta 2007;1772:32-9. (Pubitemid 44960724)